Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015574 · ClinicalTrials.gov registry record
Air Pollution and Implantable Cardioverter Defibrillators
A clinical trial of Arrythmias, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT00015574 is a study of Arrythmias that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00015574, a study of Arrythmias, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Community based studies have shown increased cardiovascular mortality associated with acute exposures to particulate air pollution. Electrocardiographic changes have also been reported in animals exposed to particles in controlled conditions. We have hypothesized that cardiovascular patients may experience life-threatening arrhythmias associated with particulate air pollution episodes. Implanted cardioverter defibrillator (ICD) devices continuously monitor the heart rhythm, and on detecting arrhythmias can initiate interventions. These devices provide a passive, continuous monitor of cardiac arrhythmias. We are assessing the association between community exposures to air pollution measured by ambient monitors and these cardiac arrhythmias detected by implanted cardioverter defibrillator devices.
Conditions Studied
Study Locations (1)
Massachusetts
- New England Medical Center, Cardiac Arrhythmia Service - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 1998-09 |
| Est. Completion | 2004-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00015574
The ClinicalTrials.gov registry entry for NCT00015574 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arrythmias appearing as the primary indexed condition, and to 0 interventions.
NCT00015574 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00015574 about?
NCT00015574 is a clinical study titled "Air Pollution and Implantable Cardioverter Defibrillators". Community based studies have shown increased cardiovascular mortality associated with acute exposures to particulate air pollution. Electrocardiographic changes have also been reported in animals exposed to particles in controlled conditions. We have hypothesized that cardiovascular patients may exp...
What is the current status of trial NCT00015574?
This trial is currently completed. The enrollment target is 500 participants. The study started on 1998-09. Estimated completion is 2004-09.
What conditions does trial NCT00015574 study?
This clinical trial studies the following conditions: Arrythmias.
Who is sponsoring clinical trial NCT00015574?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00015574 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.